Thomas Colarusso

Thomas Colarusso

Co-founder & CEO

Bio-AI Health

A veteran business executive with 20 years’ experience who has a proven track record in developing life sciences and diagnostics businesses. He has held commercial leadership positions at companies including Definiens, PathAI & HalioDx. He was a key member of the Definiens commercial leadership team who build the tissue biomarker services business and subsequently sold the company to AstraZeneca Medimmune for $150m upfront payment + milestones in Nov 2014.

Thomas has extensive experience in developing technology platform businesses used to help improve and accelerate biomarker development, anatomical pathology, clinical trials and companion diagnostics assays used to aid patient selection for novel drug targeted therapy programs.

Other speakers in 2020

Elli Karagianni

Belgium

Elli Karagianni

SNE/ Scientific Project Officer
Innovative Medicines Initiative 2 JU
Lena Rogovin

Israel

Lena Rogovin

Senior Digital Health Analyst and Sector Lead
Start-Up Nation Central
Deyan Denev

Bulgaria

Deyan Denev

Director
Association of Research-based Pharmaceutical Manufacturers Bulgaria (ARPHARM Bulgaria)
Аli Pirzada

Bulgaria

Аli Pirzada, MD

Head of Forensic and Integrity Services in Bulgaria, N. Macedonia, Albania and Kosovo
EY
Menu
Skip to content